Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises GB HoldCo on its takeover bid for Gunnebo
Mandate

Vinge advises GB HoldCo on its takeover bid for Gunnebo

September 28, 2020 Banking and Finance Commercial Agreements EU, Competition and Regulatory Capital Markets and Public M&A M&A IT, Telecommunications and Outsourcing Intellectual Property

Altor Fund V and Stena Adactum AB have, through the jointly controlled company GB HoldCo AB, announced a recommended cash offer to the shareholders of Gunnebo Aktiebolag. The offer values Gunnebo at approximately SEK 2.4 billion.

Gunnebo develops, manufactures, markets and sells security products, software and services. The Company has its headquarters in Gothenburg with operations globally through own presence in approximately 25 countries. In addition, Gunnebo's products and solutions are sold in more than 100 markets through comprehensive distribution networks.

Vinge’s team consisted of David Andersson, Erik Sjöman, Amanda Knutsson and Julia Hirschberg (Capital Markets and Public M&A), Christina Kokko, Maria Dahlin Kolvik, Desirée Sjöblom, Elsie Nassar and Carl Fredrik Wachtmeister (M&A), Louise Brorsson Salomon, Linn Adelwald, Pauline Lagerstrand and Hannes Pettersson (Banking and Finance) Johan Karlsson and Johan Wahlbom (Competition law), Sofia Bergenstråhle (IP), Karl-Hugo Engdahl (IT) and Jolene Reimerson (Commercial Agreements).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025